M 711

Drug Profile

M 711

Alternative Names: Moku-boi-to

Latest Information Update: 26 Aug 2002

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Antiallergics; Antiasthmatics
  • Mechanism of Action Histamine receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Allergic asthma; Atopic dermatitis

Most Recent Events

  • 22 Sep 1998 No-Development-Reported for Atopic dermatitis in Japan (Unknown route)
  • 31 Jul 1998 Profile reviewed
  • 31 Oct 1996 An in vitro study has been added to the Musculoskeletal Disorders and Skin Disorders pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top